GORE® Septal Occluder European Union Clinical Evaluation

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions

Closure; Foramen Ovale

Interventions

DEVICE

Closure, Foramen Ovale

Trial Locations (9)

Aarhus University Hospital, Aarhus

Rigshospitalet, Copenhagen

German Heart Center, Berlin

University Medical Center of Freiburg, Freiburg im Breisgau

Heidelberg University Hospital, Heidelberg

German Heart Center, Munich

Hospital Group of San Donato, San Donato

Karolinska University Hospital, Stockholm

Leeds Teaching Hospitals, Leeds

All Listed Sponsors

lead

W.L.Gore & Associates

INDUSTRY

NCT01605851 - GORE® Septal Occluder European Union Clinical Evaluation | Biotech Hunter | Biotech Hunter